MOBI · Mobia Medical, Inc.
$10.88
-0.18 (-1.63%)
At close · Jul 24
Going-concern doubt
— cleared Jun 4, 2026
The latest filing states the doubt was alleviated.
“the Company had previously concluded that the aforementioned factors raised substantial doubt about its ability to continue as a going concern. In May 2026, the Company completed its IPO and received net proceeds of approximately $134.5 million. As a result, the Company’s cash on hand, together with the net proceeds received from the IPO, is now expected to be sufficient to fund the Company’s operations for at least one year from the date these condensed unaudited interim financial statements are issued.”View the 10-Q filed Jun 4, 2026
Market Cap
$360.75M
Shares
33.25M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Reza Zadno, Ph.D. | Class III director | Appointed | 2026-07-15 |